[Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T lymphocytes in EBV-related diseases]

Identification of a naturally processed HLA-Cw7-binding peptide that cross-reacts with HLA-A24-restricted ovarian cancer-specific CTLs.

Tissue antigens·2015

Antileukemia multifunctionality of CD4(+) T cells genetically engineered by HLA class I-restricted and WT1-specific T-cell receptor gene transfer.

Leukemia·2015

Construction and molecular characterization of a T-cell receptor-like antibody and CAR-T cells specific for minor histocompatibility antigen HA-1H.

Gene therapy·2014

HLA-restricted presentation of WT1 tumor antigen in B-lymphoblastoid cell lines established using a maxi-EBV system.

Cancer gene therapy·2012

HapMap SNP Scanner: an online program to mine SNPs responsible for cell phenotype.

Tissue antigens·2012

Intracellular interferon-γ staining analysis of donor-specific T-cell responses in liver transplant recipients.

Transplantation proceedings·2012

[Treatment landscape of mature NK/T-cell lymphomas: treatment outcomes in Japan and future prospects].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Prophylactic or pre-emptive therapy with azacitidine or FLT3 inhibitor after allogeneic hematopoietic stem cell transplantation for AML and MDS].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Prophylactic use of tyrosine kinase inhibitors after allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Development of universal off-the-shelf T cell therapies derived from ES/iPS cells for leukemia and COVID-19].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Predictors of treatment-free remission (TFR) and second TFR attempts in chronic myeloid leukemia].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Complement-coagulation crosstalk in immunothrombosis].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

Sintilimab‑related cystitis/ureteritis in high‑grade endometrial stromal sarcoma: A case report and structured literature review.

Human vaccines & immunotherapeutics·2026

Multimodal discovery of a pathogenic B cell-dependent T cell state in multiple sclerosis.

Brain : a journal of neurology·2026

Phase I Evaluation of Siltartoxatug, a First-in-Class Anti-Tetanus Monoclonal Antibody: Safety, Pharmacokinetics and Pharmacodynamics in Healthy Australian and Chinese Populations.

Clinical pharmacology and therapeutics·2026

Thiolutin alleviates acute graft-versus-host disease (aGVHD) in a mouse model of allogeneic hematopoietic stem cell transplantation.

Blood science (Baltimore, Md.)·2026

Diagnostic Challenge of Immune Checkpoint Inhibitor-Induced Hypophysitis in Patient With Melanoma.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2026

Thymic regeneration and tumor immunotherapy.

Frontiers in immunology·2026

Related Experiment Videos

[Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T lymphocytes in EBV-related diseases]

Related Concept Videos

Identification of a naturally processed HLA-Cw7-binding peptide that cross-reacts with HLA-A24-restricted ovarian cancer-specific CTLs.

Antileukemia multifunctionality of CD4(+) T cells genetically engineered by HLA class I-restricted and WT1-specific T-cell receptor gene transfer.

Construction and molecular characterization of a T-cell receptor-like antibody and CAR-T cells specific for minor histocompatibility antigen HA-1H.

HLA-restricted presentation of WT1 tumor antigen in B-lymphoblastoid cell lines established using a maxi-EBV system.

HapMap SNP Scanner: an online program to mine SNPs responsible for cell phenotype.

Intracellular interferon-γ staining analysis of donor-specific T-cell responses in liver transplant recipients.

[Treatment landscape of mature NK/T-cell lymphomas: treatment outcomes in Japan and future prospects].

[Prophylactic or pre-emptive therapy with azacitidine or FLT3 inhibitor after allogeneic hematopoietic stem cell transplantation for AML and MDS].

[Prophylactic use of tyrosine kinase inhibitors after allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia].

[Development of universal off-the-shelf T cell therapies derived from ES/iPS cells for leukemia and COVID-19].

[Predictors of treatment-free remission (TFR) and second TFR attempts in chronic myeloid leukemia].

[Complement-coagulation crosstalk in immunothrombosis].

Sintilimab‑related cystitis/ureteritis in high‑grade endometrial stromal sarcoma: A case report and structured literature review.

Multimodal discovery of a pathogenic B cell-dependent T cell state in multiple sclerosis.

Phase I Evaluation of Siltartoxatug, a First-in-Class Anti-Tetanus Monoclonal Antibody: Safety, Pharmacokinetics and Pharmacodynamics in Healthy Australian and Chinese Populations.

Thiolutin alleviates acute graft-versus-host disease (aGVHD) in a mouse model of allogeneic hematopoietic stem cell transplantation.

Diagnostic Challenge of Immune Checkpoint Inhibitor-Induced Hypophysitis in Patient With Melanoma.

Thymic regeneration and tumor immunotherapy.

Related Experiment Videos

[Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T lymphocytes in EBV-related diseases]

Related Concept Videos

Related Articles